(19)
(11) EP 1 276 730 A2

(12)

(88) Date of publication A3:
21.02.2002

(43) Date of publication:
22.01.2003 Bulletin 2003/04

(21) Application number: 01932617.2

(22) Date of filing: 24.04.2001
(51) International Patent Classification (IPC)7: C07D 277/34, C07D 417/12, C07D 417/14, C07J 3/00, A61K 31/426, A61K 31/427, A61K 31/4439, A61K 31/497, A61K 31/56, A61P 3/10
(86) International application number:
PCT/US0113/131
(87) International publication number:
WO 0108/1328 (01.11.2001 Gazette 2001/44)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 24.04.2000 US 199146 P
06.04.2001 US 281982 P

(71) Applicant: ARYx Therapeutics
Sunnyvale, CA 94089 (US)

(72) Inventors:
  • DRUZGALA, Pascal
    Santa Rosa, CA 95409 (US)
  • MILNER, Peter, G.
    Los Altos Hills, CA 94022 (US)
  • PFISTER, Jurg, R.
    Los Altos, CA 94024 (US)

(74) Representative: Perry, Robert Edward et al
GILL JENNINGS & EVERYBroadgate House7 Eldon Street
London EC2M 7LH
London EC2M 7LH (GB)

   


(54) THIAZOLIDINEDIONE ANALOGUES AND THEIR USE FOR THE TREATMENT OF DIABETES